Webdisclosure.com

Search

NICOX (EPA:COX) Nicox Reports Positive Results of Secondary Analyses from Phase 2 Trial Further Highlighting Potential of NCX 470 in Glaucoma

Directive transparence : information réglementée

22/10/2019 07:30